Personalized Glaucoma Coaching for Glaucoma
(SEE Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a personalized coaching program, called Personalized Glaucoma Coaching, helps glaucoma patients adhere to their eye drop routines more effectively than standard care with educational materials. The coaching includes sessions with a trained advisor who assists patients in overcoming obstacles to regular medication use. Patients with glaucoma or suspected glaucoma who take and manage their own eye drop medication are suitable candidates. The study also examines whether this coaching reduces stress related to managing glaucoma. As an unphased trial, it offers patients the chance to explore innovative support methods to enhance treatment adherence and reduce stress.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. It focuses on improving adherence to eye drop medications for glaucoma.
What prior data suggests that the Personalized Glaucoma Coaching Program is safe?
Research shows that the Support, Educate, Empower (SEE) personalized Glaucoma Coaching Program helps people with glaucoma take their eye drop medication more regularly. The program uses motivational conversations and tailored education. Studies have found that participants in the SEE program significantly improved in following their medication schedules.
The program includes in-person coaching sessions and follow-up phone calls. Reports indicate no harmful side effects from this type of coaching. It is a non-medical approach, focusing mainly on providing support and education to help people adhere to their treatment plan.
Therefore, the SEE program appears safe, with no known risks from the coaching itself. Participants can expect assistance in managing their treatment without concerns about safety issues from the program.12345Why are researchers excited about this trial?
Researchers are excited about Personalized Glaucoma Coaching because it offers a new approach to improving medication adherence for glaucoma patients. Unlike the standard of care options like medicated eye drops or surgeries that focus primarily on treating the condition itself, this coaching program targets the human behavior aspect of treatment. By using motivational interviewing and tailored education, it helps patients overcome personal barriers to taking their medications consistently. This personalized support, combined with reminders like visual or audible alerts, aims to ensure patients stick to their medication schedules, potentially leading to better overall management of their glaucoma.
What evidence suggests that the Personalized Glaucoma Coaching program is effective for improving medication adherence in glaucoma patients?
Research has shown that personalized coaching for glaucoma, which participants in this trial may receive, helps patients take their medication more consistently. Patients who received this coaching reported increased confidence in managing their condition. One study found that even a year after the coaching ended, patients maintained better medication habits than before they started. This suggests that the coaching program can lead to lasting improvements in how patients manage their eye health.16789
Who Is on the Research Team?
Paula Newman-Casey, MD MS
Principal Investigator
University of Michigan
Suzanne Winter, MS
Principal Investigator
University of Michigan
Are You a Good Fit for This Trial?
This trial is for English-speaking glaucoma patients who are currently using eye drop medication and have not had recent or planned glaucoma surgery. It's not suitable for those with cognitive impairments, serious mental illnesses like schizophrenia, active eye infections, uveitis, or who can't manage their own eye drops.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive personalized glaucoma coaching or enhanced standard care for 6 months
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Enhanced Standard care
- Personalized Glaucoma Coaching
Trial Overview
The SEE Program offers personalized coaching to help improve how well patients stick to their glaucoma medication routine compared to just getting extra educational materials. The program includes motivational talks and education from a non-doctor coach.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
This is a six-month personalized glaucoma coaching program where a coach trained in motivational interviewing (MI)-based counseling uses a web-based tool that generates tailored education to help glaucoma patients identify their barriers to optimal medication adherence and explore potential solutions during three in-person coaching sessions. The coach provides between-session support through four phone calls, with two phone calls between the first and second sessions and one call after each subsequent session. Participants can elect to receive any of the following types of alarm when a dose of medication is due: visual or audible alert or automated text or phone call reminder. Glaucoma medication adherence will be monitored electronically for all participants between the baseline visit and the exit visit six months later.
Participants will receive non-tailored educational materials about glaucoma from leading sources by mail every 2 months for a total of 3 mailings during the 6-month study period. Glaucoma medication adherence will be monitored electronically for all participants between the baseline visit and the exit visit six months later.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Michigan
Lead Sponsor
National Eye Institute (NEI)
Collaborator
Citations
Glaucoma Patient Perspectives on Effective Coaching for ...
In semi-structured exit interviews, participants in a personalized glaucoma coaching program reported improved self-efficacy in managing their disease.
2.
journals.lww.com
journals.lww.com/glaucomajournal/abstract/9900/glaucoma_patient_perspectives_on_effective.562.aspxGlaucoma Patient Perspectives on Effective Coaching for Self
In semi-structured exit interviews, participants in a personalized glaucoma coaching program reported improved self-efficacy in managing their disease.
The Support, Educate, Empower (SEE) Personalized ...
This study is a two-site randomized controlled trial enrolling 230 participants with poor self-reported glaucoma medication adherence.
Impact of the Support, Educate, Empower Personalized ...
The 38 participants completed the Eye Drop Technique Self-Efficacy Scale (EDTSES) at baseline and then again 1 month after the glaucoma ...
Glaucoma Medication Adherence 1 Year after the Support, ...
Glaucoma medication adherence decreased significantly in the year after cessation of the SEE coaching program but remained significantly higher than baseline ...
Ophthalmology Glaucoma
The SEE program participants showed clinically meaningful, statistically significant improvement in glaucoma medication adherence.
The Support, Educate, Empower (SEE) Program
As a secondary outcome, the study will test whether glaucoma related distress decreases among SEE program participants compared to the control ...
Glaucoma Medication Adherence One Year After the ...
The largest monthly losses occurred at months 1 (mean=7%, p=0.0001) and 4 (mean=6%, p=0.0077). Conclusions: Glaucoma medication adherence decreased ...
Glaucoma Medication Adherence 1 Year after the Support ...
In conclusion, participants who underwent the SEE personalized glaucoma coaching program had improved glaucoma medication adherence 1 year after ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.